tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
US Market
LXRX
Lexicon Pharmaceuticals
RESEARCH TOOLSreports

Lexicon Pharmaceuticals (LXRX) Stock News & Sentiment

Compare
1,765 Followers
Lexicon Pharmaceuticals Launches Equity Offering to Fund Pipeline
Premium
Company Announcements
Lexicon Pharmaceuticals Launches Equity Offering to Fund Pipeline
2d ago
8K
LXRX
Lexicon Pharmaceuticals: Global INPEFA Expansion and Late-Stage Pipeline Catalysts Support Buy Rating and $4 Target
Premium
Ratings
Lexicon Pharmaceuticals: Global INPEFA Expansion and Late-Stage Pipeline Catalysts Support Buy Rating and $4 Target
11d ago
LXRX
Lexicon Pharmaceuticals: Late-Stage Pipeline Catalysts and Strategic Partnerships Underpin Buy Rating
Premium
Ratings
Lexicon Pharmaceuticals: Late-Stage Pipeline Catalysts and Strategic Partnerships Underpin Buy Rating
17d ago
LXRX
Lexicon Pharmaceuticals: Buy Rating Backed by Promising Cardiovascular and Neuropathic Pain Advances
Premium
Ratings
Lexicon Pharmaceuticals: Buy Rating Backed by Promising Cardiovascular and Neuropathic Pain Advances
2M ago
LXRX
Lexicon Pharmaceuticals Files Prospectus for Stock Sale
Premium
Company Announcements
Lexicon Pharmaceuticals Files Prospectus for Stock Sale
3M ago
8K
LXRX
Promising Potential of Lexicon Pharmaceuticals’ Sotagliflozin in Cardiometabolic Treatments: Analyst Recommends Buy Rating
Premium
Ratings
Promising Potential of Lexicon Pharmaceuticals’ Sotagliflozin in Cardiometabolic Treatments: Analyst Recommends Buy Rating
3M ago
LXRX
Lexicon Pharmaceuticals: Promising Developments and Strategic Progress Justify Buy Rating
Premium
Ratings
Lexicon Pharmaceuticals: Promising Developments and Strategic Progress Justify Buy Rating
3M ago
LXRX
More LXRX News >

LXRX News on the Web

Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat
TipRanks News
Bearish
Lexicon 32M share Spot Secondary priced at $1.30
TipRanks News
Neutral
Lexicon Pharmaceuticals Launches Equity Offering to Fund Pipeline
TipRanks News
Neutral
Lexicon announces common stock offering, no amount given
TipRanks News
Neutral
Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
TipRanks News
Bullish
Lexicon Gets FDA Go-Ahead For Phase 3 Pilavapadin Trials In Diabetic Nerve Pain; Stock Up
rttnews
Bullish
Lexicon (LXRX) Receives FDA Green Light for Phase 3 Trials on Pilavapadin
GuruFocus News
Bullish
Piper Sandler Sticks to Its Buy Rating for Lexicon Pharmaceuticals (LXRX)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
LXRX
Sector Average
Media Buzz
This Week4 articles
Weekly Average3.25 articles
News Sentiment
This Week0%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LXRX’s Media Buzz Sentiment?
4 articles about LXRX were published this week. In an average week, 3.25 articles are published.
    What is LXRX’s weekly average amount of articles?
    In an average week, 3.25 articles about LXRX are published.
      What is LXRX’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      IMAImageneBio
      HOCPFHOYA
      CBLControl Bionics Ltd.
      CRDFCardiff Oncology
      QNCXQuince Therapeutics
      Showing the stocks with the most bullish news sentiment over the past week